Inhibition of tau aggregation and associated cytotoxicity on neuron-like cells by calycosin

Int J Biol Macromol. 2021 Feb 28:171:74-81. doi: 10.1016/j.ijbiomac.2020.12.030. Epub 2020 Dec 7.

Abstract

In this study, the in vitro assembly of tau and anti-amyloidogenic properties of one naturally occurring phytoestrogen, calycosin, was investigated by spectroscopic techniques including ThT and ANS fluorescence, CD, Congo red absorbance as well as TEM analysis. Afterwards the cytotoxicity of different amyloid species against SH-SY5Y cells was evaluated by MTT assay. Fluorescence spectroscopic studies revealed that calycosin exerts its anti-amyloidogenic effects through increasing the lag time and reducing the apparent growth rate constant (kapp), the amount of fibrillation, and the exposure of hydrophobic regions. Congo red absorbance and CD studies indicated that calycosin prevented the formation of tau aggregate species and β-sheets structures, respectively. TEM analysis also determined the capacity of calycosin to inhibit tau fibrillogenesis through formation of large amorphous aggregates. Furthermore, cellular assays disclosed that calycosin mitigated the cell mortality, LDH release, ROS level, and expression of Bax, Bcl-2, and Caspase-3 in both mRNA and protein levels induced by tau amyloid fibrils. In conclusion, this data may suggest that calycosin can prevent tau amyloid fibrillation and the associated cytotoxicity, mainly due to its effects on formation of lower content of oligomeric and fibrillar aggregates with lower solvent-exposed hydrophobic patches compared to those produced in the absence of calycosin.

Keywords: Amyloid; Anti-amyloidogenic; Calycosin; Cytotoxicity; Tau.

MeSH terms

  • Caspase 3 / genetics
  • Caspase 3 / metabolism
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Gene Expression Regulation
  • HEK293 Cells
  • Humans
  • Isoflavones / pharmacology*
  • L-Lactate Dehydrogenase / metabolism
  • Neurons / drug effects*
  • Neurons / pathology
  • Neuroprotective Agents / pharmacology*
  • Protein Aggregates / drug effects*
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Reactive Oxygen Species / antagonists & inhibitors
  • Reactive Oxygen Species / metabolism
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • bcl-2-Associated X Protein / genetics
  • bcl-2-Associated X Protein / metabolism
  • tau Proteins / chemistry*
  • tau Proteins / genetics
  • tau Proteins / metabolism

Substances

  • BAX protein, human
  • BCL2 protein, human
  • Isoflavones
  • MAPT protein, human
  • Neuroprotective Agents
  • Protein Aggregates
  • Proto-Oncogene Proteins c-bcl-2
  • Reactive Oxygen Species
  • Recombinant Proteins
  • bcl-2-Associated X Protein
  • tau Proteins
  • 7,3'-dihydroxy-4'-methoxyisoflavone
  • L-Lactate Dehydrogenase
  • CASP3 protein, human
  • Caspase 3